We are dedicated to developing innovative medicines that can help to bring value to patients living with serious diseases. One very important step in this process is clinical trials.
From first-in-man administration to commercialization, we are pursuing clinical studies involving thousands of patients around the world. Our teams provide global support to achieve regulatory approvals, as well as post-approval and life-cycle management initiatives. Our Clinical Development operations range from early-stage to full clinical development management of the organization's clinical trials. In addition, our Medical Organization, focused on advancing scientific and medical knowledge, manages Phase IV studies and registries.